Skip to content

Clinical Evaluation of the Revised iLTS-D2

Clinical Evaluation of the Revised iLTS-D2 in Effectivity and Practicability

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03942809
Acronym
iLTS-D2
Enrollment
40
Registered
2019-05-08
Start date
2019-08-13
Completion date
2020-04-15
Last updated
2020-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Airway Management

Keywords

Airway Morbidity

Brief summary

A interventional, non-randomized, controlled study to evaluate the revised iLTS-D2 in anesthetized patients.

Detailed description

The revised Intubation laryngeal tube - disposable (iLTS-D) is a refined laryngeal tube, which allows a secondary intubation over the inserted laryngeal tube. The present study should reveal the effectiveness and practicability in anesthetized patients in the operation room.

Interventions

DEVICEEffectiveness

Effectiveness and Practicability in anesthetized patient under controlled conditions

Sponsors

Johannes Gutenberg University Mainz
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* elective surgery patients under general Anesthesia

Exclusion criteria

* Age \<18 years * Existing pregnancy * Lack of consent * inability to consent * emergency patients

Design outcomes

Primary

MeasureTime frameDescription
Insertion time LTin 30 secondsInsertion of the laryngeal tube

Secondary

MeasureTime frameDescription
Insertion time ETin 60 secondsInsertion of the endotracheal tube
Rate of successful Intubation attemptsthrough study completion, an average of 120 secondssuccessful insertion and tracheal intubation
hemodynamics MAPthrough study completion, an average of 360 secondschanges in MAP (mmHg) during cuff insufflation of laryngeal tube
hemodynamics Freqthrough study completion, an average of 360 secondschanges in heart frequency (bpm)
hemodynamics rO2through study completion, an average of 360 secondschanges in cerebral oxygenation (percent)

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 11, 2026